{"database": "lobbying", "table": "lobbying_activities", "rows": [[2676791, "e4ca9ade-9f3d-4c13-9472-29806d8e8b3d", "Q3", "AMERICAN CAPITOL GROUP", 305852, "IPSEN BIOPHARMACEUTICALS, INC.", 2021, "third_quarter", "MMM", "Medicare Part D issues.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2021-10-06T15:51:26.753000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2676791"], "units": {}, "query_ms": 11.709031881764531, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}